Don Bailey
Director/Board Member at LINEAGE CELL THERAPEUTICS, INC.
Net worth: 235 025 $ as of 2024-03-30
Profile
Don Matthew Bailey is an Independent Director at Lineage Cell Therapeutics, Inc. and a Director at Chapman University, the University of California, Irvine, and Cove Management LLC.
He previously served as President, Chief Executive Officer & Director at Questcor Pharmaceuticals, Inc., Chairman at Comarco, Inc., and Non-Executive Chairman at Asterias Biotherapeutics, Inc. He was also an Independent Director at STAAR Surgical Co., Mallinckrodt Plc, Biotie Therapies Oy, and OncoCyte Corp.
Bailey holds a graduate degree from the University of Southern California, an undergraduate degree from Drexel University, and an MBA from Pepperdine University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-02-07 | 158,801 ( 0.08% ) | 235 025 $ | 2024-03-30 |
Don Bailey active positions
Companies | Position | Start |
---|---|---|
LINEAGE CELL THERAPEUTICS, INC. | Director/Board Member | 2019-03-07 |
Chapman University | Director/Board Member | - |
University of California, Irvine | Corporate Officer/Principal | - |
Cove Management LLC
Cove Management LLC Investment ManagersFinance Cove Management LLC (Cove Fund) is a venture capital firm founded in 2014. The firm is headquartered in Irvine, California. | Consultant / Advisor | - |
Former positions of Don Bailey
Companies | Position | End |
---|---|---|
ASTERIAS BIOTHERAPEUTICS INC | Chairman | 2019-03-07 |
ONCOCYTE CORPORATION | Director/Board Member | 2017-11-17 |
BIOTIE THERAPIES CORP | Director/Board Member | 2016-04-30 |
MALLINCKRODT PLC | Director/Board Member | 2016-02-29 |
QUESTCOR PHARMACEUTICALS INC | Chief Executive Officer | 2014-08-13 |
Training of Don Bailey
University of Southern California | Graduate Degree |
Drexel University | Undergraduate Degree |
Pepperdine University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
STAAR SURGICAL COMPANY | Health Technology |
LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
MALLINCKRODT PLC | Health Technology |
ONCOCYTE CORPORATION | Health Technology |
Private companies | 6 |
---|---|
Comarco, Inc.
Comarco, Inc. Wireless TelecommunicationsCommunications Comarco, Inc. engaged in the development of technologies in the field of power adapters and chargers for portable mobile devices, which included laptop computers and tablets smartphones. The company was founded in 1960 and was headquartered in Laguna Niguel, CA. | Communications |
Questcor Pharmaceuticals, Inc.
Questcor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Questcor Pharmaceuticals, Inc. was engaged in development, marketing and sale of prescription drugs. It operated as a biopharmaceutical company which focuses on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders. The company's primary product was H.P. Acthar Gel, an injectable drug for the treatment of proteinuria in the nephrotic syndrome of the idiopathic type, or NS, the treatment of acute exacerbations of multiple sclerosis, or MS, in adults, the treatment of infantile spasms, or IS, in infants and children under two years of age, and the treatment of certain rheumatology related conditions, including the treatment of the rare and closely related neuromuscular disorders dermatomyositis and polymyositis. Questcor Pharmaceuticals was founded in September 1992 and was headquartered in Anaheim, CA. | Health Technology |
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Biotie Therapies Oy
Biotie Therapies Oy Pharmaceuticals: MajorHealth Technology Biotie Therapies Oy engages in the research, development, and commercialization of pharmaceutical products. The company was founded by Markku Tapani Jalkanen and Sirpa Tuulikki Jalkanen in June 1992 and is headquartered in Helsinki, Finland. | Health Technology |
Canon STAAR Co., Inc. | Health Technology |
Cove Management LLC
Cove Management LLC Investment ManagersFinance Cove Management LLC (Cove Fund) is a venture capital firm founded in 2014. The firm is headquartered in Irvine, California. | Finance |
- Stock Market
- Insiders
- Don Bailey